Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


GMO suppliers attracted to African cowpea market

The potential adoption genetically modified cowpeas in three West African countries is attracting the attention of global seed supplying companies, according to a report released this months.  The African Centre for Biodiversity (ACB) report claims that the “GM cowpea push in Burkina Faso, Nigeria and Ghana coincides” with multinational and local seed companies’ interest to produce foundation and certified seed in West Africa. The report is entitled: GM and seed industry eye Africa’s lucrative cowpea seed markets: The political economy of cowpea in Nigeria, Burkina Faso, Ghana and Malawi. GM cowpeas contain the Cry1Ab Bt gene, developed by Monsanto and donated since it has come off patent, to the African Agricultural Technology Foundation cowpea project, ostensibly on a “humanitarian basis” — royalty free, the report says. The project counts on international funding and is targeted towards Nigeria, Ghana, Burkina Faso and Malawi.  GM pod borer (Maruca vitrata)-resistant cowpeas are reportedly due to be introduced in the region by 2017.



What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts